Back to today’s briefing

Story perspectives

FDA Moves to Classify Synthetic Opioid as Controlled Substance

8/5/2025

36 8

Summary

Story summary

The U.S. FDA is taking a bold step to combat the opioid crisis by recommending that synthetic 7-hydroxymitragynine (7-OH) be classified as a controlled substance. This move seeks to shield young people from deceptive kratom products, while the DEA prepares to gather public feedback on this crucial decision.

1 of 1

Story summary

The U.S. FDA is taking a bold step to combat the opioid crisis by recommending that synthetic 7-hydroxymitragynine (7-OH) be classified as a controlled substance. This move seeks to shield young people from deceptive kratom products, while the DEA prepares to gather public feedback on this crucial decision.